These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6686848)

  • 41. Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
    Kosmas C; Tsavaris NB; Malamos NA; Vadiaka M; Koufos C
    J Clin Oncol; 2001 Jan; 19(1):119-26. PubMed ID: 11134204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
    Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N
    J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.
    Tannehill SP; Mehta MP; Larson M; Storer B; Pellet J; Kinsella TJ; Schiller JH
    J Clin Oncol; 1997 Aug; 15(8):2850-7. PubMed ID: 9256128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.
    Fuks JZ; Aisner J; Van Echo DA; Schipper H; Levitt M; Ostrow S; Wiernik PH
    J Clin Oncol; 1983 May; 1(5):295-301. PubMed ID: 6686849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Adelson MD; Hanjani P
    Invest New Drugs; 1990 Nov; 8(4):377-9. PubMed ID: 2084071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.
    Albain KS; Swinnen LJ; Erickson LC; Stiff PJ; Fisher RI
    Cancer Chemother Pharmacol; 1990; 27(1):33-40. PubMed ID: 2245491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
    Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
    Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II evaluation of fractionated low and single high dose cisplatin in various tumors.
    Schilcher RB; Wessels M; Niederle N; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1984; 107(1):57-60. PubMed ID: 6538200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lung.
    Tapazoglou E; Haas CD; Samson MK; Baker LH; Pazdur R
    Am J Clin Oncol; 1985 Aug; 8(4):298-301. PubMed ID: 3002165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site.
    Hainsworth JD; Dial TW; Greco FA
    Am J Clin Oncol; 1988 Apr; 11(2):138-45. PubMed ID: 2451881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cis-diamminedichloroplatinum activity in bidimensionally measurable metastatic lesions of bladder carcinoma.
    De Lena M; Lorusso V; Iacobellis U; Marzullo F; Maiello E; Cramarossa A
    Tumori; 1984 Feb; 70(1):85-8. PubMed ID: 6538708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II study of five-day continuous infusion of vinblastine in patients with metastatic renal-cell carcinoma.
    Crivellari D; Tumolo S; Frustaci S; Galligioni E; Figoli F; Lo Re G; Veronesi A; Monfardini S
    Am J Clin Oncol; 1987 Jun; 10(3):231-3. PubMed ID: 3591744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II study of cisplatin in advanced gastric cancer.
    Beer M; Cocconi G; Ceci G; Varini M; Cavalli F
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):717-20. PubMed ID: 6683644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small cell lung cancer: results of a phase II study of 1,2,4 triglycidylurazol.
    Cunningham D; Banham SW; Soukop M
    Cancer Chemother Pharmacol; 1986; 17(1):85-6. PubMed ID: 3009043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity.
    Salem P; Khalyl M; Jabboury K; Hashimi L
    Cancer; 1984 Feb; 53(4):837-40. PubMed ID: 6537893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
    Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.